REQUEST A DEMO
Total
USD $0.00
Search more companies

Pyxis Pharmaceutical Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Grocery and Related Product Merchant Wholesalers | Direct Selling Establishments
Full name: Pyxis Pharmaceutical Sas Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Pyxis Pharmaceutical Sas is an enterprise in Colombia, with the main office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on September 17, 2019. 8 (2026) employees currently work for Pyxis Pharmaceutical Sas. The latest financial highlights indicate a net sales revenue increase of 132.1% in 2025. Its’ total assets recorded a growth of 61.64%. The net profit margin of Pyxis Pharmaceutical Sas increased by 7.75% in 2025.

Headquarters
Calle 120A No.7-93
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Pyxis Pharmaceutical Sas report to view the information.

Basic Information
Total Employees:
Purchase the Pyxis Pharmaceutical Sas report to view the information.
Financial Auditors:
Purchase the Pyxis Pharmaceutical Sas report to view the information.
Incorporation Date:
September 17, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Pyxis Pharmaceutical Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
132.1%
Total Operating Revenue
132.1%
Operating Profit
869.71%
Net Profit/Loss for the Period
703.95%
Total Assets
61.64%
Total Equity
255.41%
Operating Profit Margin
17.24%
Net Profit Margin
7.75%
Return on Equity (ROE)
40.09%
Quick Ratio
0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?